According to the news from China National Intellectual Property Administration in August, 2020, the application for "recombinant novel coronavirus vaccine with human replication-defective adenovirus as the vector" jointly filed by Academician Chen Wei of Academy of Military Medical Sciences and Kangxinuo Bio has obtained the patent right. Inventors include Chen Wei, Wu Shipo, Hou Lihua, Zhang Zhe and others.
This vaccine is the adenovirus vector vaccine (Ad5-nCoV vaccine) developed by Academician Chen Wei. This is the first COVID-19 vaccine patent in China. This patent was filed on March 8, 2020 and granted on August 8, 2020. It can be mass-produced in a short time.